U.S. Semiconductors Stock News

NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

A Look At Tetra Tech (TTEK) Valuation After New US$100 Million Air Force Contract Win

Fresh contract win puts Air Force work in focus Tetra Tech (TTEK) recently announced a US$100 million, five year multiple award contract to provide planning and assessment services for Air Force Civil Engineer Center projects, highlighting its role in environmental and infrastructure consulting. See our latest analysis for Tetra Tech. The Air Force contract arrives as the share price sits at US$36.45, with a 7 day share price return of 10.86% and a 1 year total shareholder return of 26.02%...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher’s Candida Auris Test Launch Meets Valuation And Momentum Crossroads

Thermo Fisher Scientific (NYSE:TMO) has launched new chromogenic culture media for faster detection and differentiation of clinically important Candida species. The media are designed to help laboratories identify drug resistant Candida auris, a growing global health concern linked to difficult to treat fungal infections. This launch is positioned as a tool to support infection control efforts and improve the management of fungal outbreaks in healthcare settings. Thermo Fisher Scientific,...
NYSE:FTI
NYSE:FTIEnergy Services

Is It Too Late To Consider TechnipFMC (FTI) After Its Strong Multi‑Year Rally?

If you are wondering whether TechnipFMC at US$66.13 is still offering value or if most of the upside is already reflected in the price, you are in the right place. The stock has recently shown strong momentum, with returns of 1.1% over the last 7 days, 18.7% over the past month, 39.8% year to date, 146.6% over 1 year, 344.1% over 3 years and a very large gain over 5 years that is close to 7x. Recent coverage around TechnipFMC has focused on its position in the energy sector and how investors...
NYSE:ASB
NYSE:ASBBanks

Is Associated Banc-Corp (ASB) Attractive After Regional Banking Sector Reassessment?

If you are wondering whether Associated Banc-Corp is offering fair value right now, it helps to start by looking at what the recent share price is telling you about expectations and risk. The stock last closed at US$26.36, with returns of a 3.2% decline over 7 days, a 3.3% decline over 30 days, a 2.3% gain year to date, 16.5% over 1 year, 34.9% over 3 years and 46.5% over 5 years. This gives you a sense of how sentiment has shifted over different time frames. Recent news coverage has focused...
NYSE:MDT
NYSE:MDTMedical Equipment

What Medtronic (MDT)'s European MiniMed Go Smart MDI Rollout Means For Shareholders

Medtronic has recently begun the commercial rollout across Europe of its MiniMed Go Smart MDI system, which combines data from the InPen smart insulin pen and Simplera continuous glucose sensor into a single mobile app for people managing diabetes with multiple daily injections. This integrated solution marks a meaningful step in connecting insulin delivery and glucose monitoring data, potentially improving day-to-day decision support for European diabetes patients who are not using insulin...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

A Look At Exelixis (EXEL) Valuation As Analyst Optimism Builds Around Its Oncology Pipeline

Recent analyst actions around Exelixis (EXEL) have put the stock back on many investors’ watchlists, as firms update ratings and earnings forecasts following its oncology pipeline progress. See our latest analysis for Exelixis. That renewed analyst interest sits against a mixed price backdrop, with a 7 day share price return of 9.75% and a 90 day share price return of 7.43% pointing to fading short term momentum. At the same time, the 3 year total shareholder return of 147.21% and 5 year...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron’s Expanded Cellular‑Mesh UtilityIQ Platform Might Change The Case For Investing In Itron (ITRI)

Itron, Inc. recently expanded its UtilityIQ Application Suite to support new Cellular 500G and 500W modules for gas and water meters in the US, enabling utilities to combine cellular and mesh connectivity over its Gen6 network platform. A particularly important angle is that the upgraded, multi-transport headend and interoperable cellular modules let utilities mix vendors and deployment models without overhauling existing infrastructure. We’ll now examine how this enhanced cellular‑mesh...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet (ZBH) Valuation Check As AAOS 2026 Robotics And Smart Implant Showcase Nears

Zimmer Biomet Holdings (ZBH) is drawing fresh attention after detailing plans to showcase robotics, AI-driven navigation tools and smart implant technology at the AAOS 2026 Annual Meeting in New Orleans. See our latest analysis for Zimmer Biomet Holdings. The recent product showcase around robotics, AI tools and smart implants comes after a 12.52% 1 month share price return and an 8.83% year to date share price return. However, the 1 year total shareholder return of 4.86% and 5 year total...
NasdaqCM:IMPP
NasdaqCM:IMPPOil and Gas

Assessing Imperial Petroleum (IMPP) Valuation As Earnings Date Nears And Fleet Expansion Takes Shape

Upcoming earnings release and fleet expansion put Imperial Petroleum in focus Imperial Petroleum (IMPP) has drawn fresh attention after scheduling its Q4 and full-year 2025 results for March 6, 2026, along with plans to grow its fleet from 20 to 26 vessels. See our latest analysis for Imperial Petroleum. At a share price of US$4.10, Imperial Petroleum has seen a 16.15% 1 month share price return and a 12.33% year to date share price return. Its 1 year total shareholder return of 70.12%...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside

BeOne Medicines, listed as NasdaqGS:ONC, announced new collaborations with Amgen, Bristol Myers Squibb, and Novartis. The partnerships are focused on advancing BeOne Medicines' oncology therapy pipeline alongside its existing commercial products. The company also highlighted ongoing clinical trials that sit alongside these new pharma alliances. BeOne Medicines operates in oncology, an area where large pharma groups and smaller specialists often work together to bring new treatments through...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth Magnet Push Links Valuation Upside To Geopolitical Supply Shifts

USA Rare Earth (NasdaqGM:USAR) is expanding into domestic rare-earth magnet manufacturing as part of U.S. efforts to reduce reliance on Chinese supply. The company acquired U.K.-based LCM, adding established magnet technology and production capabilities to its portfolio. USA Rare Earth has started magnet production in Stillwater, Oklahoma, with a focus on serving defense and advanced manufacturing customers. These steps come as geopolitical tensions, including conflict in Iran and Chinese...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

How Investors Are Reacting To Kiniksa (KNSA) Turning ARCALYST Revenue Into Full-Year Profitability And Flexibility

Kiniksa Pharmaceuticals International, plc recently reported past fourth-quarter and full-year 2025 results, with revenue rising to US$202.13 million for the quarter and US$677.56 million for the year, alongside a swing from a prior net loss to net income of US$14.2 million and US$59.01 million respectively. The company also filed a US$149.83 million shelf registration for employee share offerings and is set to present at TD Cowen’s 46th Annual Health Care Conference, underscoring how...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

CHMP Setback Puts Acadia Rett Plans And Revenue Outlook In Focus

CHMP issued a negative opinion on ACADIA Pharmaceuticals' trofinetide marketing application for Rett syndrome in Europe. Acadia has requested a re examination of the opinion, triggering a formal review process. The decision affects prospects for European access to trofinetide and is drawing close attention from investors and patients. For investors watching NasdaqGS:ACAD, the regulatory setback comes with the stock trading around $22.5 and recent returns showing mixed signals. Shares are...
NYSE:KEY
NYSE:KEYBanks

KeyCorp CIO Resignation Puts Focus On Technology Continuity And Valuation

KeyCorp (NYSE:KEY) announced the resignation of Chief Information Officer Amy Brady for health reasons. Brady, a long-tenured technology leader at the bank, is stepping down as the company sets up an interim leadership structure. The transition plan includes reassignment of her responsibilities to maintain continuity in KeyCorp’s technology and operations. For a bank like KeyCorp, which operates across retail, commercial, and wealth management services, technology sits at the core of how it...
NYSE:HNI
NYSE:HNICommercial Services

HNI Reshapes Portfolio As Acquisitions Lift Revenue But Pressure Margins

HNI (NYSE:HNI) has reported strong revenue growth tied to major acquisitions of Kimball and assets from Steelcase. The company has also reworked its portfolio through restructuring efforts and the divestiture of HNI India. These changes come as HNI absorbs integration costs while still reporting revenue that outpaced earlier expectations. For investors watching NYSE:HNI, the share price sits at $43.67, with a 3 year return of 60.6% and a 5 year return of 27.5%. Short term moves have been...
NYSE:JPM
NYSE:JPMBanks

Is JPMorgan Chase (JPM) Still Attractive After Recent 1-Year Rally In The Share Price

If you are wondering whether JPMorgan Chase at around US$300.26 is still reasonably priced or already baking in a lot of optimism, you are not alone. The stock has returned 1.0% over the last 7 days, a 1.8% decline over the past month, is down 7.7% year to date, yet shows a 22.4% return over 1 year and a 124.6% return over 5 years, which can change how investors think about both its growth potential and risk. Recent headlines have focused on JPMorgan Chase's position as a large US bank and...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Assessing Capital Clean Energy Carriers (CCEC) Valuation After €250 Million Unsecured Bond Offering

Capital Clean Energy Carriers (CCEC) has just priced a €250 million unsecured bond offering in Greece, an event that reshapes its funding mix and near term financial flexibility for existing shareholders. See our latest analysis for Capital Clean Energy Carriers. At a share price of $23.08, Capital Clean Energy Carriers has seen an 11.87% 90 day share price return and a 13.07% year to date share price return. Its 1 year total shareholder return of 26.99% and 5 year total shareholder return of...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

UroGen’s ZUSDURI Data And Reimbursement Progress Shift Risk Reward Profile

UroGen Pharma (NasdaqGM:URGN) reported durable complete response rates for ZUSDURI across all recurrence risk groups in its Phase 3 ENVISION trial in recurrent non muscle invasive bladder cancer. The company highlighted ZUSDURI as a non surgical option for patients with limited treatments today. Adoption of ZUSDURI is picking up following the activation of a permanent J code, which supports reimbursement and broader patient access. UroGen Pharma focuses on urologic cancers, where many...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

Why United States Antimony (UAMY) Is Up 14.6% After Advancing Its Fostung Tungsten Defense Plans

United States Antimony recently completed an initial resource engineering study for its 100%-owned Fostung Tungsten Property in Ontario, confirming an inferred resource of 53.595 million pounds of tungsten trioxide and initiating plans to seek U.S. Government funding under the Defense Production Act to fast-track development for defense supply chains. This combination of a defined tungsten resource and a formal push for Defense Production Act support highlights the company’s expanding role...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Charter Communications (CHTR) Valuation Check After CALNET Spectrum Business Expansion

Charter Communications (CHTR) has expanded its Spectrum Business offerings under California’s CALNET contract by adding Managed Network Services, Unified Communications with RingCentral, and new fiber connectivity options for state and local agencies. See our latest analysis for Charter Communications. Despite the CALNET expansion and recent leadership news, Charter’s 1-month and 3-month share price returns of 11.3% and 14.7% contrast with a 1-year total shareholder return decline of 37.7%...
NYSE:KR
NYSE:KRConsumer Retailing

The Bull Case For Kroger (KR) Could Change Following A Premium Private Label Meal Expansion - Learn Why

In March 2026, Kroger expanded its Private Selection brand with more than 20 premium, globally inspired ready-to-eat and ready-to-cook meals, available exclusively across its family of stores and digital channels. This push into higher-quality, convenience-focused private label meals highlights how Kroger is leaning on differentiated own brands to keep value-conscious, time-pressed shoppers within its ecosystem as competition intensifies. We’ll now examine how this broadened Private...
NYSE:M
NYSE:MMultiline Retail

Macy's 5% Dividend Increase Highlights Capital Returns And Cash Flow Focus

Macy's (NYSE:M) has increased its regular quarterly dividend by 5%. The higher payout will apply to upcoming dividend distributions to shareholders. Macy's, trading around $18.28, is sending a clear signal about its priorities with this 5% dividend increase. The move comes after a mixed share price pattern, with a 7 day return of 12.2% decline and a 30 day return of 8.7% decline, but a 1 year return of 43.5%. For investors focused on income, the step up in the regular payout can be an...
NYSE:USPH
NYSE:USPHHealthcare

A Look At U.S. Physical Therapy (USPH) Valuation After 2025 Results And New Hospital Affiliations

U.S. Physical Therapy (USPH) is back in focus after reporting 2025 results that included higher net revenue and adjusted EBITDA, along with two new hospital affiliations that are expected to expand its clinic footprint from mid 2026. See our latest analysis for U.S. Physical Therapy. At a share price of US$83.25, U.S. Physical Therapy has posted a 10.4% 3 month share price return and a 7.3% 1 year total shareholder return, with longer term total returns still in decline. This suggests recent...
NYSE:UDR
NYSE:UDRResidential REITs

UDR CEO Conference Spotlight Links Dividend Story And Capital Priorities

UDR (NYSE:UDR) has announced that its Chairman, President & CEO will present at Citi’s Miami Global Property CEO Conference. The appearance follows the company’s release of new investor materials and regulatory filings. The conference slot is expected to focus on UDR’s current disclosures, capital allocation priorities, and portfolio positioning. UDR is a multifamily real estate investment trust focused on apartment communities, a segment that often sits at the intersection of housing...